Security key
13471N300
Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF)
CUSIP: 13471N300
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Ordinary Shares, no par value
- Total 13F shares
- 243,810
- Total 13F value
- $536,298
- Share change
- +176,168
- SEC-reported price per share
- $2.20
- Number of holders
- 8
- Value change
- +$381,921
- Number of buys
- 5
- Number of sells
- 3
- Shares outstanding
- 3,838,602,439
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
8
Top holders
8
CANF full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Can-Fite BioPharma Ltd. SEC filings
Can-Fite BioPharma Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 13471N300
Recent filing periods:
Ownership snapshot
Top reported holders of CANF - Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MORGAN STANLEY
Disclosed value leader
MORGAN STANLEY
Comparable rows
9/9
Latest evidence
30 Sep 2023
13F
Lead comparable stake: 0%
Showing 1-6 of 9 holder rows.
Quick read
MORGAN STANLEY leads the comparable SEC ownership view at 0%.
9 of 9 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MORGAN STANLEY's linked filing trail.
Comparable ownership
Top 5
MORGAN STANLEY
0%
RHUMBLINE ADVISERS
0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
0%
FIFTH THIRD BANCORP
0%
NATIONAL BANK OF CANADA /FI/
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 9 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
Company
|
0%
|
$87,465
33,007 shares
|
— | 30 Sep 2023 |
| RHUMBLINE ADVISERS |
13F
Company
|
0%
|
$47,493
17,922 shares
|
— | 30 Sep 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0%
|
$31,923
12,047 shares
|
— | 30 Sep 2023 |
| FIFTH THIRD BANCORP |
13F
Company
|
0%
|
$7,950
3,000 shares
|
— | 30 Sep 2023 |
| NATIONAL BANK OF CANADA /FI/ |
13F
Company
|
0%
|
$1,476
600 shares
|
— | 30 Sep 2023 |
| CITIGROUP INC |
13F
Company
|
0%
|
$1,465
553 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
8
Shares
243,810
Rows available
8
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q4 2025 Across Filers
Q4 2025 holders
13
Q4 2023 holders
8
Holder diff
-5
| Investor | Q4 2025 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q4 2025 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend